|
GWAS datasets
|
AD or AD proxy
|
Controls or proxy controls
|
|---|
|
N
|
% female
|
Mean AAO (s.d)
|
N
|
% female
|
Mean AAE (s.d)
|
|---|
|
IGAP ADGC
|
14,428
|
59.3
|
71.1 (17.3)
|
14,562
|
59.3
|
76.2 (9.9)
|
|
IGAP CHARGE
|
2137
|
67.3
|
82.6 (12)
|
13,474
|
55.8
|
76.7 (8.2)
|
|
IGAP EADI
|
2240
|
65
|
75.4 (9.1)
|
6631
|
60.6
|
78.9 (7.0)
|
|
IGAP GERAD
|
3177
|
64
|
73.0 (0.2)
|
7277
|
51.8
|
51.0 (0.1)
|
|
UK Biobank AD proxy
|
42,034
|
65.9
|
-
|
272,244
|
-
|
-
|
|
Maternal AD group from UK Biobank
|
27,696
|
100
|
-
|
260,980
|
-
|
-
|
|
Paternal AD group from UK Biobank
|
14,338
|
0
|
-
|
245,941
|
-
|
-
|
- AD Alzheimer’s disease, AAO age at onset, AAE age at examination
